Although the underlying molecular mechanisms behind IDH mutation and its proposed influences on diagnosis, prognosis and the suggested predictive capacity of the mutation are yet to be identified, there appears to be overwhelming evidence that this genetic alteration has a significant role to play in understanding the underlying pathology of gliomagenesis and tumour progression. Here, IDH2 is linked to neoplasm.